Research and application of the SARS-CoV-2 vaccine based on adenovirus vector technology platform / 中华预防医学杂志
Chinese Journal of Preventive Medicine
; (12): 1082-1095, 2023.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-985477
Responsible library:
WPRO
ABSTRACT
During the global efforts to prevent and control the COVID-19 pandemic, extensive research and development of SARS-CoV-2 vaccines using various technical approaches have taken place. Among these, vaccines based on adenovirus vector have gained substantial knowledge and experience in effectively combating potential emerging infectious diseases, while also providing novel ideas and methodologies for vaccine research and development (R&D). This comprehensive review focuses on the adenovirus vector technology platform in vaccine R&D, emphasizing the importance of mucosal immunity induced by adenoviral vector-based vaccine for COVID-19 prevention. Furthermore, it analyzes the key technical challenges and obstacles encountered in the development of vaccines based on the adenovirus vector technology platform, with the aim of providing valuable insights and references for researchers and professionals in related fields.
Full text:
Available
Health context:
SDG3 - Target 3.3 End transmission of communicable diseases
Health problem:
Pneumonia
Database:
WPRIM (Western Pacific)
Main subject:
Technology
/
Viral Vaccines
/
Adenoviridae
/
Pandemics
/
COVID-19 Vaccines
/
SARS-CoV-2
/
COVID-19
Limits:
Humans
Language:
Chinese
Journal:
Chinese Journal of Preventive Medicine
Year:
2023
Document type:
Article